Substance / Medication

Fondaparinux

Overview

Active Ingredient
fondaparinux
RxNorm CUI
321208

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

7 trials linked to this intervention

7
Total Trials
1
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review.
Stojadinovic Milorad, Jankovic Slobodan, Zivkovic-Zaric Radica et al. · Eur J Clin Pharmacol · 2025
PMID: 40925931Meta-Analysis
Comparing fondaparinux and low molecular weight heparin for thromboprophylaxis after hip and knee arthroplasty: a systematic review and meta-analysis.
Waseem Muhammad Hassan, Abideen Zain Ul, Rehman Nohela et al. · Blood Coagul Fibrinolysis · 2025
PMID: 40127127Meta-Analysis
Efficacy and safety of fondaparinux in elective total hip arthroplasty and hip fracture surgery: a systematic review and meta-analysis.
Mariscal Gonzalo, Tarazona-Santabalbina Francisco José, Marin-Peña Oliver et al. · J Orthop Surg Res · 2025
PMID: 40442800Meta-AnalysisFull text (PMC)
Safety profiles of fondaparinux in pregnant women: a systematic review and meta-analysis.
Shan Dan, Han Jinbiao, Ji Yurou et al. · Eur J Clin Pharmacol · 2025
PMID: 39836237Meta-Analysis
Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: A meta-analysis.
Mu Fangxiang, Wang Mei, Huang Jinge et al. · Eur J Obstet Gynecol Reprod Biol · 2023
PMID: 37276726Meta-Analysis
Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis.
Bundhun Pravesh Kumar, Shaik Musaben, Yuan Jun · BMC Cardiovasc Disord · 2017
PMID: 28482804Meta-AnalysisFull text (PMC)
Fondaparinux for Management of Heparin-induced Thrombocytopenia after Cardiovascular Intervention: A Systematic Review.
Bhatt Vijaya R, Dahal Sumit, Verma Vivek et al. · Cardiovasc Hematol Agents Med Chem · 2015
PMID: 26362274Meta-Analysis
[Efficacy and safety of fondaparinux versus enoxaparin for preventing venous thromboembolism after major orthopedic surgery: a meta-analysis].
Li Hu, Wang Jian, Xiao Jun et al. · Nan Fang Yi Ke Da Xue Xue Bao · 2013
PMID: 23529234Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Fondaparinux (substance)
SNOMED CT
708189008
UMLS CUI
C1098510
RxNorm CUI
321208

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
7
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.